Elizabeth Ann L Enninga1, Jin Sung Jang2,3, Benjamin Hur4,5, Erica L Johnson6, Myra J Wick1, Jaeyun Sung4,5,7, Rana Chakraborty1,8,9. 1. Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN, USA. 2. Medical Genome Facility, Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA. 3. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA. 4. Microbiome Program, Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA. 5. Division of Surgery Research, Department of Surgery, Mayo Clinic, Rochester, MN, USA. 6. Department of Microbiology, Biochemistry, and Immunology, Morehouse School of Medicine, Atlanta, GA, USA. 7. Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, MN, USA. 8. Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA. 9. Department of Immunology, Mayo Clinic, Rochester, MN, USA.
Abstract
PROBLEM: Prenatal exposure to metabolic dysregulation arising from maternal obesity can have negative health consequences in post-natal life. To date, the specific effects of maternal obesity on fetal immunity at a cellular level have not been well characterized. METHOD OF STUDY: Using cord blood mononuclear cells (CBMCs) and cord plasma (n = 9/group) isolated from infants born to women with a high body mass index (BMI>25kg/m2 ) compared to women with a normal BMI (18-25kg/m2 ), we evaluated differences in immune cell populations using single-cell mass cytometry (CyTOF). CBMCs were matched according to potentially confounding variables, such as maternal and gestational age, ethnicity, smoking status, and gravidity. Statistical results were adjusted for fetal sex. Data were analyzed by viSNE and FlowSOM softwares in Cytobank™ . RESULTS: In newborn CBMCs from women with high BMI, we observed changes in frequency and phenotype of immune cell populations, including significant increases in CD4+ T cells and decreases in myeloid cell populations. IL-12p40 and MDC concentrations were significantly elevated in the high BMI group compared to control. CONCLUSION: This study demonstrates an association between maternal obesity and fetal immunity. Our results warrant following long-term immunologic outcomes and associated clinical risks in children born to women with a high pre-pregnancy BMI.
PROBLEM: Prenatal exposure to metabolic dysregulation arising from maternal obesity can have negative health consequences in post-natal life. To date, the specific effects of maternal obesity on fetal immunity at a cellular level have not been well characterized. METHOD OF STUDY: Using cord blood mononuclear cells (CBMCs) and cord plasma (n = 9/group) isolated from infants born to women with a high body mass index (BMI>25kg/m2 ) compared to women with a normal BMI (18-25kg/m2 ), we evaluated differences in immune cell populations using single-cell mass cytometry (CyTOF). CBMCs were matched according to potentially confounding variables, such as maternal and gestational age, ethnicity, smoking status, and gravidity. Statistical results were adjusted for fetal sex. Data were analyzed by viSNE and FlowSOM softwares in Cytobank™ . RESULTS: In newborn CBMCs from women with high BMI, we observed changes in frequency and phenotype of immune cell populations, including significant increases in CD4+ T cells and decreases in myeloid cell populations. IL-12p40 and MDC concentrations were significantly elevated in the high BMI group compared to control. CONCLUSION: This study demonstrates an association between maternal obesity and fetal immunity. Our results warrant following long-term immunologic outcomes and associated clinical risks in children born to women with a high pre-pregnancy BMI.
Authors: Abhishek K Jha; Stanley Ching-Cheng Huang; Alexey Sergushichev; Vicky Lampropoulou; Yulia Ivanova; Ekaterina Loginicheva; Karina Chmielewski; Kelly M Stewart; Juliet Ashall; Bart Everts; Edward J Pearce; Edward M Driggers; Maxim N Artyomov Journal: Immunity Date: 2015-03-17 Impact factor: 31.745
Authors: Gabriela K Fragiadakis; Quentin J Baca; Pier Federico Gherardini; Edward A Ganio; Dyani K Gaudilliere; Martha Tingle; Hope L Lancero; Leslie S McNeil; Matthew H Spitzer; Ronald J Wong; Gary M Shaw; Gary L Darmstadt; Karl G Sylvester; Virginia D Winn; Brendan Carvalho; David B Lewis; David K Stevenson; Garry P Nolan; Nima Aghaeepour; Martin S Angst; Brice L Gaudilliere Journal: J Immunol Date: 2016-10-28 Impact factor: 5.422
Authors: Petter Brodin; Vladimir Jojic; Tianxiang Gao; Sanchita Bhattacharya; Cesar J Lopez Angel; David Furman; Shai Shen-Orr; Cornelia L Dekker; Gary E Swan; Atul J Butte; Holden T Maecker; Mark M Davis Journal: Cell Date: 2015-01-15 Impact factor: 41.582
Authors: Randall M Wilson; Nicole E Marshall; Daniel R Jeske; Jonathan Q Purnell; Kent Thornburg; Ilhem Messaoudi Journal: Pediatr Allergy Immunol Date: 2015-06 Impact factor: 5.464
Authors: R Godiska; D Chantry; C J Raport; S Sozzani; P Allavena; D Leviten; A Mantovani; P W Gray Journal: J Exp Med Date: 1997-05-05 Impact factor: 14.307